Previous 10 | Next 10 |
home / stock / seovf / seovf news
(TheNewswire) Sernova Expands Scientific Advisory Board Expertise for its Innovative Cell Therapy Therapeutic Applications in Endocrine Disorders Including Thyroid Disease LONDON, ONTARIO – TheNewswire - April 14, 2021 – Se...
(TheNewswire) LONDON, ONTARIO - TheNewswire - April 6, 2021 - Sernova Corp. (TSXV:SVA) (OTC:SEOVF) (FSE/XETRA:PSH ), a leading clinical-stage regenerative medicine therapeutics company, is pleased to announce that lead principal investigator Dr. Piotr...
NEW YORK, March 29, 2021 (GLOBE NEWSWIRE) -- Life Sciences Investor Forum today announced that the presentations from the March 25 th conference are now available for on-demand viewing at LifeSciencesInvestorForum.com. This virtual event showcased live company presentations and in...
(TheNewswire) London, ON – TheNewswire - March 23 2021 – TroyMedia Corp. i s Canad a’s latest Media leader to be draw n to Sernova Corp.’s (TSXV:SVA) (OTC:SEOVF) story and developments. ...
LONDON, Ontario, March 22, 2021 (GLOBE NEWSWIRE) -- Sernova Corp. (OTCQB:SEOVF)(TSX-V:SVA)(FSE/XETRA:PSH), a leading clinical-stage company focused on developing regenerative medicine therapeutics company, today announced that Dr. Philip Toleikis, President and CEO will present liv...
NEW YORK , March 19, 2021 (GLOBE NEWSWIRE) -- Life Sciences Investor Forum today announced the agenda for its quarterly event for public and private companies, investors and industry professionals from around the world. This day-long virtual event will showcase live company presentations an...
(TheNewswire) LONDON, ONTARIO – TheNewswire - March 1, 2021 – Sernova Corp. (“Sernova” or the “Company”) (TSXV:SVA) (OTC:SEOVF) (Frankfurt/Xetra:PSH) , a leading clinical-stage regenerative medicine therapeu...
(TheNewswire) L ondon, Ontario - TheNewswire - February 25, 2021 - Sernova Corp. (TSXV:SVA) (OTC:SEOVF) (Frankfurt/Xetra:PSH), a clinical-stage company and leader in regenerative medicine therapeutics is pleased to announce that the TSX Venture Stock Exch...
(TheNewswire) LONDON, ONTARIO - TheNewswire – February 24, 2021 – Sernova Corp. ("Sernova" or the "Company") (TSXV:SVA) (OTC:SEOVF) (Frankfurt/Xetra:PSH), a leading clinical-stage regenerative medicine therapeutics company, is pleased ...
(TheNewswire) Ongoing Safety of Sernova's Clinical Trial Confirmed L ondon, Ontario - TheNewswire - February 18, 2021 - Sernova Corp. (TSXV:SVA) (OTC:SEOVF) (FSE:PSH), a clinical-stage company and leader in regenerative medicine therapeutics, is p...
News, Short Squeeze, Breakout and More Instantly...
(TheNewswire) LONDON, Ontario; BOSTON, Massachusetts – TheNewswire - July 15, 2024 – Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage biotechnology company focused on the development of regenerative medicine cell therapies for treatment o...
(TheNewswire) To date Sernova reports 7 patients in its Phase I/II type 1 diabetes clinical trial achieved freedom from insulin injections and demonstrate blood sugar control in the non- diabetic range (HbA1c 6.5%); 6 patients have reached between 5.5 and 50 months o...
(TheNewswire) LONDON, Ontario; BOSTON, Massachusetts – June 12, 2024 – TheNewswire – Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage biotechnology company focused on the development of regenerative medicine cell therapies for treatmen...